Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Inlyta is a prescription kidney cancer treatment medication used specifically to treat renal cell carcinoma. It will be prescribed when the cancerous tumor in the kidney or the cancer has metastasized and spread to other parts of the body, and it is also common for it to be used along with avelumab or pembrolizumab for initial RCC cancer treatment. The active ingredient in this medication – Axitinib – is a kinase inhibitor that works by starving the tumor and taking away its ability to grow. By using Inlyta medication in this way the patient has the potential for better treatment outcomes with chemotherapy or other approaches.
You can buy Inlyta with a prescription, and your best price on it will be when you order medication online from us.
Standard dosage for Inlyta when treating renal cell carcinoma is to take Inlyta 5mg 2x daily, with doses taken 12 hours apart. Medication can be taken with or without food.
Patients with liver problems may have their doctor specify a lower dose, and you should always take your medication exactly as indicated in your prescription.
The active ingredient in Inlyta is Axitinib.
Tell your doctor if you have any history of heart failure, hypertension, hypothyroidism, liver problems, gastrointestinal perforation, blood clots, or bleeding problems before starting on Inlyta medication.
Women who are pregnant or breastfeeding should not use Inlyta unless their doctor approves it.
Inlyta may decrease fertility in both men and women temporarily while they are using the medication.
Patients of either gender taking Inlyta are advised to use birth control while taking this medication.
There is the possibility of negative drug interactions between Inlyta and other Rx or OTC medications, including allopurinol / amlodipine / aspirin / atorvastatin / nebivolol / carvedilol / ubiquinone / furosemide / gabapentin / hydralazine / pembrolizumab / furosemide / levothyroxine / lisinopril / lorazepam / losartan / omeprazole / ondansetron / oxycodone / cholecalciferol.
Tell your doctor of all medications you are currently taking before receiving a prescription and proceeding to buy Inlyta online.
Inlyta side effects are a possibility, and some users may experience nausea, diarrhea, constipation, vomiting, hair loss, fatigue, muscle or bone pain, mouth sores, loss of appetite, rash, cough, breathing difficulties, abdominal pain, headache, speaking difficulties, or protein in urine. If Inlyta side effects are experienced, you may want to discontinue use and speak to your doctor again regarding kidney cancer treatment medication alternatives.